Matthew L. Meyerson
M.D., Ph.D.
Professor, Department of Medical Oncology
👥Biography 个人简介
Matthew Meyerson is a cancer genomics expert who has discovered multiple cancer driver genes through systematic genomic analysis. His work on EML4-ALK fusion in lung cancer and telomerase promoter mutations has led to development of targeted therapies and diagnostic biomarkers.
Matthew Meyerson是癌症基因组学专家，通过系统的基因组分析发现了多个癌症驱动基因。他在肺癌EML4-ALK融合和端粒酶启动子突变方面的工作导致了靶向治疗和诊断生物标志物的开发。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
ALK Fusion Discovery
Identified EML4-ALK fusion as targetable lung cancer driver.
TERT Promoter
Discovered TERT promoter mutations across cancer types.
Representative Works 代表性著作
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Nature (2007)
Discovery of ALK fusion in lung cancer.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew L. Meyerson 的研究动态
Follow Matthew L. Meyerson's research updates
留下邮箱，当我们发布与 Matthew L. Meyerson（Dana-Farber Cancer Institute / Broad Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment